A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on HumanPapillomavirus16-transformed HLA-A2+Epithelial Cancers

FDA Advisory Committee supports second HPV vaccine

(2009) Carrie Printz   CANCER

Vaccinology in the genome era

(2009) C. Daniela Rinaudo et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions

(2009) Valeria Cento et al.   JOURNAL OF MEDICAL VIROLOGY

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Distribution of HLA-A, -B, -Cw, and -DRB1 alleles and haplotypes in an isolated Han population in Southwest China

(2009) Y. Yao et al.   TISSUE ANTIGENS

Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research

(2008) Hong Lin et al.   BMC IMMUNOLOGY

NetMHCpan, a method for MHC class I binding prediction beyond humans

(2008) Ilka Hoof et al.   IMMUNOGENETICS

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia

(2008) Muriel van den Hende et al.   INTERNATIONAL JOURNAL OF CANCER

Structural Analysis Reveals an Amyloid Form of the Human Papillomavirus Type 16 E1 E4 Protein and Provides a Molecular Basis for Its Accumulation

(2008) P. B. McIntosh et al.   JOURNAL OF VIROLOGY

The IMGT/HLA database

(2008) J. Robinson et al.   NUCLEIC ACIDS RESEARCH

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

(2008) John T. Schiller et al.   VACCINE